HemaSphere Journal/X
Jun 23, 2025, 11:26
VEXAS Syndrome Research by Pierre Sujobert Awarded by HemaSphere
“ At EHA2025, HemaSphere was honored to award authors of 4 recent + highly influential publications that significantly contribute to the hematology field. Congrats to Pierre Sujobert + coauthors for their study on vacuolization of myeloid precursors in VEXAS syndrome.”
Explore more on Hemostasis Today.
-
Nov 14, 2026, 09:37Chronic Preoperative Corticosteroid Use and Postoperative Venous Thromboembolism Risk – Thrombosis and Haemostasis Journal
-
Nov 14, 2026, 09:30Ney Carter Borges: Vulnerable Plaque – Imaging and Clinical Significance
-
Nov 14, 2026, 09:25Carmelo Raffo: How Much Antithrombotic Therapy is Truly Necessary after LAAC?
-
Nov 14, 2026, 09:19Mary Cushman: Excellent to Have Jordan Shavit Visit Us for a Virtual Lab Meeting Today
-
Nov 14, 2026, 09:15Chancellor Donald: Heading to ASH 2026 in New Orleans? Let’s Connect on Faculty Opportunities at Tulane
-
Nov 14, 2026, 09:11Sajja Venkatesh: FDA Approved Asundexian, the First Factor XIa Inhibitor
-
Nov 14, 2026, 09:05Selina Evans: How Can Hospitals Make VTE Risk Assessment and Prevention Truly Routine?
-
Nov 14, 2026, 09:01Abdul Rehman Abid: DAPT vs Aspirin Monotherapy Beyond 12 Months Following Drug-Eluting Stent Implantation
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
